DDD Partners LLC Buys New Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

DDD Partners LLC purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 642 shares of the medical equipment provider's stock, valued at approximately $318,000.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Chilton Capital Management LLC boosted its position in Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 43 shares during the period. Parvin Asset Management LLC bought a new stake in Intuitive Surgical during the 4th quarter valued at $26,000. Global Financial Private Client LLC increased its position in shares of Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after purchasing an additional 38 shares during the period. Elite Financial Inc. acquired a new position in shares of Intuitive Surgical during the 1st quarter valued at $26,000. Finally, Hurley Capital LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter valued at $28,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Robert Desantis sold 188 shares of the company's stock in a transaction on Monday, April 28th. The shares were sold at an average price of $515.91, for a total value of $96,991.08. Following the completion of the sale, the executive vice president owned 5,224 shares in the company, valued at $2,695,113.84. This represents a 3.47% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Mark Brosius sold 216 shares of the company's stock in a transaction on Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the sale, the senior vice president owned 907 shares of the company's stock, valued at approximately $510,740.77. This represents a 19.23% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 4,998 shares of company stock worth $2,611,577. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock traded up $1.68 on Friday, hitting $517.84. 759,480 shares of the company's stock traded hands, compared to its average volume of 1,680,880. The firm's 50-day moving average price is $536.26 and its two-hundred day moving average price is $536.13. The stock has a market capitalization of $185.60 billion, a PE ratio of 75.98, a price-to-earnings-growth ratio of 5.44 and a beta of 1.64. Intuitive Surgical, Inc. has a one year low of $413.82 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same quarter in the previous year, the company posted $1.50 EPS. On average, analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the company. Truist Financial reduced their price objective on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research note on Wednesday, April 23rd. Piper Sandler decreased their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research report on Wednesday, April 23rd. Citigroup reaffirmed a "buy" rating and issued a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Royal Bank Of Canada decreased their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Finally, Evercore ISI raised their target price on Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a research report on Tuesday, July 8th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $592.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.